Representation

Polpharma Group is a high quality European Pharma and biotech manufacturer and a reputable business partner for pharmaceutical companies worldwide. They grow their presence through B2B activities, including API custom development and manufacturing in their cGMP-compliant and FDA-approved facility, out-licensing of vertically integrated solutions from API to finished formulation, and contract manufacturing services covering a wide variety of solid and liquid forms. They are also a fully integrated, state-of-the-art biotechnology player mastering all steps of the cell culture value chain from cell line via process and product development to GMP manufacturing up to commercial scale, applying this to own biosimilars and contract-manufacturing.

The Uquifa group is a cGMP producer of Active Pharmaceutical Ingredients (APIs) and intermediates. The group operates 3 FDA inspected plants in Spain (2) and Mexico. With approximately 600,000 litres of reactor capacity, a complete range of chemical capabilities are available and include hydrogenation, chlorination, micronization and so forth. Highly qualified R&D teams and versatile pilot plants are available for product development, scale-up and commercialization, in addition to supplying API to the Generics Industry. Custom synthesis is conducted with the highest degree of confidentiality. Products - supplied to more than 500 companies in more than 60 countries globally- cover a wide range of therapeutic categories.

For decades Polymed Therapeutics has been a leading global manufacturer and distributor of Active Pharmaceutical Ingredients (cGMP API). They are committed to the highest quality products, at the most competitive pricing. Headquartered in USA, Polymed has several state-of-the-art GMP manufacturing facilities and R&D laboratories in China. Their API facility is GMP APPROVED by FDA, EU and JAPAN ! Their APIs are used in ANDA/NDA approved drugs in US, EU, Asia & MENA. Pharmaceutical grade APIs include: DOCETAXEL, CABAZITAXEL, PACITAXEL, Irinotecan, Oxaliplatin, Azacytidine, Bortezomib, Decitabine, Cholecalciferol (Vit D3), Ergocalciferol (Vit D2), Vit D Analogs: Doxercalciferol, Calcitriol, Paricalcitol, plus Pharma Grade Sucralose.

Cipla Limited is an Indian multinational pharmaceutical company, headquartered in Mumbai, India. Cipla primarily develops medicines to treat respiratory disease, cardiovascular disease, arthritis, diabetes, depression and many other medical conditions.

Umicore Precious Metals Chemistry strengths are a combination of customer orientation, process excellence, innovation leadership and diversity. Their customer focused technology platforms align worldwide all necessary resources from Research & Development to Marketing & Sales through Production, providing expertise in transition metals chemistry, high potency APIs, catalysts and high purity chemicals manufacturing, and related applications. It offers first class products and services allowing customers to use metal based technologies in the most effective and sustainable way. Umicore PMC's advanced chemicals and catalysts are mostly used in the industrial synthesis of active pharmaceutical ingredients, polymers, automotive catalytic converters or electronic materials. Products: Active Pharmaceutical Ingredients, Exclusive Synthesis of APIs, Homogeneous Catalysts, Pharmaceutical Intermediates.

Emcure is a fast-growing Indian pharmaceutical company engaged in developing, manufacturing, and marketing a broad range of biopharmaceutical products globally. Emcure's differentiated product portfolio lends an unparalleled competitive advantage establishing its presence in all major therapies in the domestic market. With a presence in over 70 countries, Emcure's goal is to constantly innovate and deliver affordable & high-quality healthcare solutions to people.

Glenmark: The generics business services the requirements of developed markets like US and Western Europe. Glenmark's API business sells products in over 65 countries including the US, various countries in the EU, South America and India.

Noucor key elements of value proposition are innovation and talent as they add excellency to the provided service. They aim to work closely with our customers and suppliers and to become a trustworthy strategic partner.

Their International presence makes them exceptional partner for the development of worldwide added-valued Pharma drugs.

Zhejiang Hisun Chemical Co., Ltd (hereafter called as ”Hisun Chemical), founded in 1998, is a state-holding enterprise invested by State Development & Investment Corporation(SDIC), Zhejiang Hisun Group and ZMC Co., Ltd. The company now covers an area of 312,000 square meters and 35‰ of its staff members are technicians.

With its total assets of nearly USD 60 million, Hisun Chemical has created a niche in agrochemical field through its sustainable researching, marketing efforts and strong distribution network. The company, with its headquarter located in Taizhou, Zhejiang, now has two wholly-owned subsidiary companies , two Sino-foreign joint ventures and one Provincial Hi-tech R&D Centre.

Apothecon is a research based pharmaceutical company located at Vadodara, in Gujarat State of India. They conduct research and development for their own and to support their global business partners in development of quality products. Company adhere national and international GMP guidance for Designing, Developing, Maintaining Facility, Processes and Products. The site is US FDA & MHRA inspected facility registered with US FDA and certified for complying GMP by FDCA Gujarat, India and WHO.

We as (Igenerix) are partner / consultant for Unilab from almost a decade. Unilab is a number one Pharma company in Philippines and top 10 in ASEAN. Unilab believe that every Filipino should receive unparalleled care when it comes to health. This means going above and beyond one's call of duty to be able to provide for customer's health needs.

We partnered a Good Quality Insulin Pen, Auto Injector Pen Supplier From China - Jiangsu Delfu medical device Co.,Ltd.

GEN is the leading specialty pharmaceutical company in Turkey with more than 20 years of experience.

GEN partners with global pharmaceutical companies to bring innovative therapies and rare solutions to our community. We work compliant with ethical and scientific principles and strive to set the best standards for quality, safety, and value in the manufacture and access to health care products.